- Arsenal hit back in style after Southampton scare
- Hezbollah heir apparent Safieddine out of contact after strikes
- Liverpool stay top of Premier League as Arsenal, Man City win
- In dank Tour of Emilia, Pogacar shines in rainbow jersey
- DR Congo launches mpox vaccination drive, hoping to curb outbreak
- Trump returns to site of failed assassination
- Careless Leverkusen held to Bundesliga draw
- O'Brien's 'superstar' Kyprios posts landmark win on Arc weekend
- Liverpool suffer Alisson injury blow
- Habosi helps Racing beat Vannes before Auradou's playing return
- Thousands march in London in support of Palestinians, 1 year after Oct 7
- Israel readying response to Iran missile attack
- Schutt, Mooney help Australia beat Sri Lanka in Women's T20 World Cup
- Liverpool extend Premier League lead with win at Palace
- Djokovic 'shakes rust off' to make third round of Shanghai Masters
- 'Imperfect' PSG fighting on all fronts - Luis Enrique
- Struggling Pakistan look to thwart adaptable England
- Child 'trampled to death' in asylum seekers' Channel crossing: minister
- Gauff fights back to set up Beijing final against Muchova
- Guardiola claims Premier League won't delay season for Man City
- Israel to mark October 7 attack as Gaza war spreads
- Gauff fights back to reach China Open final
- Recovering Stokes ruled out of first Pakistan Test
- Hezbollah battles troops on border as Israel pounds Lebanon
- Alcaraz, Sinner breeze into third round of Shanghai Masters
- Bagnaia wins Japan MotoGP sprint to cut Martin's lead
- Alcaraz breezes into third round of Shanghai Masters
- Gaza cultural heritage brought to light in Geneva
- 'Bullet for democracy': Trump returns to site of rally shooting
- Italy targets climate activists in 'anti-Gandhi' demo clampdown
- South Korean cult-horror series 'Hellbound' returns at BIFF
- Nepalis fear more floods as climate change melts glaciers
- Honduras arrests environmentalist's alleged murderer
- Padres pitcher Musgrove needs elbow surgery
- Supreme Court lets stand rules to curb mercury, methane emissions
- Boston beat Denver in NBA exhibition season opener, but Jokic says omens are good
- Chagos diaspora angry at lack of input on islands' fate
- Biden says 'not confident' of peaceful US election
- US trade chief defends tariff hikes when paired with investment
- Lukaku stars as Napoli beat Como to hold Serie A top spot
- Ohtani set for MLB playoff debut as Dodgers face Padres
- Pogba's drug ban cut to 18 months from four years
- Devine leads New Zealand to big win over India in Women's T20 World Cup
- Bosnia floods kill 16 people
- EU court blocks French ban on vegetable 'steak' labelling
- Prosecutors seek dismissal of rape charges against French rugby players
- Meta AI turns pictures into videos with sound
- Bolivia's Morales says claims he raped a minor are a 'lie'
- MLB Reds hire two-time champion Francona as manager
- Daniel Maldini receives first Italy call-up for Nations League
Chinese drug giant halts trading as US move triggers stock plunge
Wuxi Biologics suspended trading in Hong Kong on Tuesday following a record slump in its share price, after Washington added the Chinese pharmaceutical giant to a list that could restrict its US operations.
The Department of Commerce on Monday said the company was among 33 Chinese entities added to its unverified list, which may force it to obtain additional licences to do business with American firms.
Wuxi Biologics, which produces vaccines and drugs on contract for pharmaceutical firms, said the move would have "no impact" on its business and that it was "in compliance with all US export control regulations".
But its shares plunged as much as 32 percent in Hong Kong on Tuesday before suspending trading down 23 percent at HK$62.25.
The company has expanded aggressively in recent years with a 1.3 million-square-foot production facility set to open in the western Chinese city of Chengdu next year, according to its website.
It signed an agreement with GlaxoSmithKline and Vir Biotechnology to produce Covid-19 antibody treatment Sotrovimab in 2020, and took over a Bayer factory in Germany last year to produce Covid-19 vaccines.
The United States has added a number of Chinese companies to official lists in recent years, curtailing their ability to do business at a time of heightened tensions between the world's two biggest economies.
The addition of Huawei to the so-called entity list -- as well as subsequent moves against the telecom giant -- have barred it from buying crucial components and decimated its once-thriving smartphone business.
F.Moura--PC